Dr. Ali is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Henry Ford Health System
2799 Wgrand BLVD
Detroit, MI 48202Phone+1 313-916-7648
Education & Training
Ascension Providence/MSUCHMFellowship, Hematology and Medical Oncology, 1996 - 1998- Ascension Providence/MSUCHMResidency, Internal Medicine, 1993 - 1996
University of Baghdad College of MedicineClass of 1988
Certifications & Licensure
MI State Medical License 1995 - 2027- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer Start of enrollment: 2007 Feb 01
- Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity Start of enrollment: 2010 Dec 01
- Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol Start of enrollment: 2014 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 1627 citationsPembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048) : a ...Barbara Burtness, Kevin J. Harrington, Richard Greil, Denis Soulières, Makoto Tahara
Lancet. 2019-11-23 - 128 citationsCommon variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagusZhan Su, Amy Strange, Claire Palles, Gavin Band, David C. Whiteman
Nature Genetics. 2012-10-01 - 747 citationsCabozantinib in Progressive Medullary Thyroid CancerRossella Elisei, Martin Schlumberger, Stefan P. Müller, Patrick Schöffski, Marcia S. Brose
Journal of Clinical Oncology. 2013-10-10
Journal Articles
- Nab-Paclitaxel plus Carboplatin or Gemcitabine vs Gemcitabine plus Carboplatin as First-Line Treatment for Patients with Triple-Negative Metastatic Breast Cancer: Resu...H Ali, A Brufsky, M Shtivelband, S Gluck, J Miller, R Young, Annals of Oncology
Press Mentions
OncLive® to Host State of the Science Summit™ on Breast CancerMay 8th, 2018
Professional Memberships
- Member
- European society of medical oncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
